Johns Hopkins University School of Medicine, Baltimore, MD.
University of Texas Medical Branch at Galveston School of Medicine, Galveston, TX.
Urology. 2023 Dec;182:211-217. doi: 10.1016/j.urology.2023.08.031. Epub 2023 Sep 9.
To assess the risk of persistent opioid use following various urologic procedures in adolescents and young adults.
The TriNetX LLC Diamond Network was queried for patients aged 13-21years who underwent pyeloplasty, hypospadias repair, inguinal hernia repair, inguinal orchiopexy, hydrocelectomy, or circumcision. Cohorts of patients prescribed and not prescribed postoperative opioids were created and propensity-matched for age, race/ethnicity, psychiatric diagnoses, and preoperative pain diagnoses. The primary outcome was new persistent opioid use, defined as new opioid use 3-9months after index procedure without another surgery requiring anesthesia during the postoperative timeframe.
Of 32,789 patients identified, 66.0% received a postoperative opioid prescription. After propensity score matching for each procedure, 18,416 patients were included: 197 for pyeloplasty, 469 for hypospadias repair, 1818 for inguinal hernia repair, 2664 for inguinal orchiopexy, 534 for hydrocelectomy, and 3526 for circumcision. Overall, 0.41% of patients who did not receive postoperative opioids developed new persistent opioid use, whereas 1.69% of patients who received postoperative opioids developed new persistent opioid use (P < .05). Patients prescribed postoperative opioids had statistically higher odds of developing new persistent opioid use for hypospadias repair (RR: 17.0; 95% CI: 2.27-127.2), inguinal orchiopexy (RR: 3.46; 95% CI: 1.87-6.4), inguinal hernia repair (RR: 2.18; 95% CI: 1.07-4.44), and circumcision (RR: 4.83; 95% CI: 2.60-8.98).
The use of postoperative opioids after urological procedures in adolescents and young adults is associated with a significant risk of developing new persistent opioid use.
评估青少年和年轻成年人接受各种泌尿科手术后持续使用阿片类药物的风险。
在 TriNetX LLC Diamond 网络中查询了接受肾盂成形术、尿道下裂修复术、腹股沟疝修补术、腹股沟或阴囊固定术、鞘膜积液切除术或包皮环切术的年龄在 13-21 岁的患者。创建了接受和不接受术后阿片类药物处方的患者队列,并根据年龄、种族/民族、精神科诊断和术前疼痛诊断进行倾向评分匹配。主要结局是新的持续性阿片类药物使用,定义为在术后时间段内没有因另一次需要麻醉的手术而使用阿片类药物,但在索引手术后 3-9 个月新使用阿片类药物。
在确定的 32789 名患者中,66.0%接受了术后阿片类药物处方。在对每种手术进行倾向评分匹配后,纳入了 18416 名患者:肾盂成形术 197 例,尿道下裂修复术 469 例,腹股沟疝修补术 1818 例,腹股沟或阴囊固定术 2664 例,鞘膜积液切除术 534 例,包皮环切术 3526 例。总体而言,未接受术后阿片类药物治疗的患者中有 0.41%发生新的持续性阿片类药物使用,而接受术后阿片类药物治疗的患者中有 1.69%发生新的持续性阿片类药物使用(P<.05)。接受术后阿片类药物处方的患者发生新的持续性阿片类药物使用的可能性统计学上更高,用于尿道下裂修复术(RR:17.0;95%CI:2.27-127.2)、腹股沟或阴囊固定术(RR:3.46;95%CI:1.87-6.4)、腹股沟疝修补术(RR:2.18;95%CI:1.07-4.44)和包皮环切术(RR:4.83;95%CI:2.60-8.98)。
青少年和年轻成年人接受泌尿科手术后使用术后阿片类药物与新的持续性阿片类药物使用风险显著增加相关。